BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 107290
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107290
Figure 1
Figure 1 The flowchart of the study. U-JIA: Uveitis associated with juvenile idiopathic arthritis; MTX: Methotrexate; bDMARDs: Biologic disease-modifying anti-rheumatic drugs.
Figure 2
Figure 2 The main eye surgeries in the patients with uveitis.
Figure 3
Figure 3 Kaplan-Meier curves. A: The probability of the remission achievement on methotrexate depending on the surgical intervention; B: The probability of biologic disease-modifying antirheumatic drug initiation depending on the surgical intervention; C: The probability of not having surgical intervention depending on the initiation time of methotrexate. bDMARDs: Biologic disease-modifying anti-rheumatic drugs.
Figure 4
Figure 4 The most common complications of uveitis associated with juvenile idiopathic arthritis. A: Band keratopathy (arrow); B Posterior synechia (arrow).